Sg Americas Securities, LLC Tg Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,730 shares of TGTX stock, worth $237,542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,730
Previous 23,614 67.27%
Holding current value
$237,542
Previous $552,000 57.79%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
SELL
$21.31 - $35.09 $338,488 - $557,369
-15,884 Reduced 67.27%
7,730 $233,000
Q3 2024

Oct 03, 2024
BUY
$17.21 - $25.28 $262,245 - $385,216
15,238 Added 181.92%
23,614 $552,000
Q2 2024

Jul 12, 2024
SELL
$13.32 - $19.19 $89,004 - $128,227
-6,682 Reduced 44.38%
8,376 $149,000
Q1 2024

May 06, 2024
SELL
$13.02 - $21.3 $67,196 - $109,929
-5,161 Reduced 25.53%
15,058 $229,000
Q4 2023

Jan 12, 2024
BUY
$6.68 - $18.81 $135,062 - $380,319
20,219 New
20,219 $345,000
Q1 2023

Apr 28, 2023
BUY
$10.23 - $19.34 $2.02 Million - $3.83 Million
197,884 New
197,884 $2.98 Million
Q3 2022

Oct 31, 2022
BUY
$4.57 - $8.4 $303,644 - $558,121
66,443 New
66,443 $393,000
Q1 2022

Apr 29, 2022
SELL
$7.81 - $20.45 $93,876 - $245,809
-12,020 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$15.2 - $35.51 $150,115 - $350,696
-9,876 Reduced 45.1%
12,020 $228,000
Q3 2021

Nov 01, 2021
BUY
$21.78 - $40.45 $355,144 - $659,577
16,306 Added 291.7%
21,896 $729,000
Q2 2021

Aug 12, 2021
SELL
$32.5 - $48.96 $520,715 - $784,437
-16,022 Reduced 74.13%
5,590 $217,000
Q1 2021

May 13, 2021
BUY
$41.61 - $54.3 $416,474 - $543,488
10,009 Added 86.26%
21,612 $1.04 Million
Q4 2020

Feb 04, 2021
SELL
$25.27 - $54.9 $1.03 Million - $2.25 Million
-40,908 Reduced 77.9%
11,603 $604,000
Q3 2020

Nov 09, 2020
BUY
$18.49 - $27.24 $718,632 - $1.06 Million
38,866 Added 284.84%
52,511 $1.41 Million
Q2 2020

Jul 20, 2020
SELL
$8.9 - $21.84 $28,551 - $70,062
-3,208 Reduced 19.04%
13,645 $266,000
Q1 2020

Apr 30, 2020
BUY
$7.14 - $15.99 $120,330 - $269,479
16,853 New
16,853 $166,000
Q4 2019

Jan 28, 2020
SELL
$5.1 - $11.2 $139,056 - $305,379
-27,266 Closed
0 $0
Q3 2019

Nov 04, 2019
SELL
$5.38 - $8.99 $19,324 - $32,292
-3,592 Reduced 11.64%
27,266 $153,000
Q2 2019

Jul 29, 2019
BUY
$6.27 - $8.65 $9,285 - $12,810
1,481 Added 5.04%
30,858 $267,000
Q1 2019

Apr 29, 2019
SELL
$4.02 - $8.04 $35,810 - $71,620
-8,908 Reduced 23.27%
29,377 $236,000
Q4 2018

Feb 01, 2019
BUY
$3.44 - $5.76 $80,024 - $133,994
23,263 Added 154.86%
38,285 $157,000
Q3 2018

Nov 06, 2018
BUY
$5.15 - $14.0 $77,363 - $210,308
15,022 New
15,022 $84,000

Others Institutions Holding TGTX

# of Institutions
363
Shares Held
91M
Call Options Held
2.34M
Put Options Held
1.72M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email